ARCHIVES

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

Roswell Park, Karmanos Read The Cancer Letter Interactive.

December 1, 2000

PIs On Both Sides of Screening Controversy Testified in Tobacco Trials.

October 26, 2007

BCDDP “Major Accomplishment” Described By ACS’ Holleb

July 21, 1978

DOD Breast Cancer Program Releases Research Solicitation

October 1, 1993

NCAB Puts 20% Cap On P01 Budget Raises To Stem Requests Exceeding NCI’s.

February 25, 2000

Barakat Named Deputy Physician-in-Chief Of Memorial Sloan-Kettering’s Regional Care Network

October 18, 2013